Pierrel operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pierrel with three other
pharmaceutical manufacturers in Europe:
sales of 150.91 million Norwegian Kroner [US$17.82 million]
of which 57%
was Hexvix/Cysview Own Sales),
Science In Sport Plc
of the United Kingdom
(£15.62 million [US$19.89 million]
of which 89%
was Core), and
Replek AD Skopje
based in Macedonia
(955.23 million Denar [US$17.70 million]
During the year ended December of 2017, sales at
Pierrel were 16.84 million Euro (US$19.22 million).
increase of 18.0%
versus 2016, when the company's sales were 14.27 million Euro.